Advertisement
Pharma/Biotech News
Subscribe to Pharma/Biotech News

The Lead

Amgen Announces Results of Phase 3 Head-to-Head Study of Drugs for Multiple Myeloma

March 2, 2015 12:59 pm | News | Comments

Patients receiving one of the medications that was tested lived twice as long without disease progression. Read more...                       

J&J Announces Binding Offer from Cardinal Health to Acquire Cordis

March 2, 2015 12:49 pm | News | Comments

The deal breaks down to an aggregate value of $1.99 billion. Read more...

An Opening for Measles

March 2, 2015 12:36 pm | by Colleen Walsh, Harvard Staff Writer | News | Comments

Anti-vaccination trend is becoming a growing concern. Read more...

Survey: Parents Increasingly Ask Doctors to Delay Vaccines

March 2, 2015 12:29 pm | by Lindsey Tanner, AP Medical Writer | News | Comments

Parents have increasingly pressured doctors to delay vaccines for young children, making their...

View Sample

FREE Email Newsletter

Daily news and top headlines for drug research professionals

Firm Agrees to Refund to Settle Suit Over Weight-Loss Pills

March 2, 2015 12:23 pm | by Associated Press | News | Comments

Salt Lake City-based company has agreed to pay refunds to consumers who purchased its weight-loss tablets to settle a class-action lawsuit. Read more...                  

FDA Approves Actavis', Medicines360's Long-Term Contraception

March 2, 2015 10:06 am | News | Comments

Actavis plc, a leading global specialty pharmaceutical company, and Medicines360, a nonprofit women's health pharmaceutical company, announced the approval of Liletta (levonorgestrel-releasing intrauterine system) by the U.S. Food and Drug Administration (FDA) for use by women to prevent pregnancy for up to three years. Read more...

Mylan Completes Acquisition Of Abbott's Non-U.S. Developed Markets

March 2, 2015 9:58 am | News | Comments

​Mylan N.V. and Mylan Inc. announced the successful completion of the acquisition of Abbott Laboratories' (NYSE: ABT) non-U.S. developed markets specialty and branded generics business. Read more..

Advertisement

First Treatment Approved in Canada for Adults With ADPKD

March 2, 2015 9:52 am | News | Comments

Otsuka Pharmaceutical Co., Ltd. and its affiliate Otsuka Canada Pharmaceutical Inc. announce that Health Canada has approved JINARC (tolvaptan) as the first pharmaceutical agent for the treatment of autosomal dominant polycystic kidney disease (ADPKD). Read more...

Lyric Pharmaceuticals: $20.4M Series A Funding Round

February 27, 2015 1:41 pm | News | Comments

Lyric Pharmaceuticals Inc. today announced the initial closing of a Series A financing round totaling $20.4 million. Read more...                                     

Former Sanofi CEO Joins Puretech’s Board of Directors

February 27, 2015 1:29 pm | News | Comments

PureTech, a science and technology R&D company focused  on identifying, inventing and commercializing disruptive products and technologies in the healthcare sector, announced today the appointment of Christopher Viehbacher, former CEO and Member of the Board of Directors of Sanofi, to its Board of Directors.  Read more...

Making Proactive Asset Management Work for Business

February 27, 2015 1:02 pm | by Ben Potenza, VP Marketing, EquipNet | Articles | Comments

Millions are spent every year on the laboratory equipment and instrumentation that is essential for the daily work of research and analysis in the pharmaceutical, biotechnology and chemical sectors. Read more...                 

Heat Blamed for Spray Vaccine's Failure Against Swine Flu

February 27, 2015 12:53 pm | by Mike Stobbe, AP Medical Writer - Associated Press | News | Comments

The makers of the nasal spray version of the flu vaccine say now they know why it has failed to protect young U.S. children against swine flu - fragile doses got too warm. Read more...

Advertisement

Takeda's Treatment for Acid-Related Diseases is Now Available in Japan

February 27, 2015 9:10 am | News | Comments

This medicine treats acid-related diseases with a novel mechanism of action called potassium-competitive acid blockers. Read more...                    

Novartis's Lung Cancer Drug Recommended for EU Approval

February 27, 2015 9:03 am | News | Comments

The medication is meant for patients with ALK+ NSCLC previously treated with crizotinib. Read more...                          

Nonprescription Diet Pill Alli Back in Stores After Recall

February 27, 2015 8:25 am | by Associated Press | News | Comments

The British drugmaker voluntary recalled the product last March after finding some packages in stores didn't contain real alli, indicating tampering after shipment. Read more...              

Sanofi Gets FDA Approval for New Insulin Drug

February 26, 2015 12:06 pm | by Stephanie Guzowski, Editor | News | Comments

Sanofi announced late Wednesday that it received approval from the U.S. Food and Drug Administration (FDA) to sell its new insulin product Toujeo. The once-daily, long-acting basal insulin will help improve glycemic control in adults with type 1 and type 2 diabetes. Read more..

Amgen: Positive Results for CKD Treatment

February 26, 2015 11:05 am | News | Comments

Amgen announced results from the head-to-head Phase 3 study comparing AMG 416 with cinacalcet for the treatment of secondary hyperparathyroidism (SHPT) in patients with chronic kidney disease (CKD) receiving hemodialysis. Read more...

Advertisement

Scientists Develop Method to Suppress Malaria Parasite's Virulence Genes

February 26, 2015 8:41 am | by Hebrew University | News | Comments

Researchers have revealed the genetic trickery this deadly parasite deploys to escape attack by the human immune system. Read more...                     

Turing Pharmaceuticals Launches

February 25, 2015 10:15 am | News | Comments

Turing Pharmaceuticals AG announced its official launch, along with news of three acquisitions for its commercial operations and development pipeline. New York-based Turing will focus on developing and commercializing innovative treatments for serious diseases and conditions across a broad range of therapeutic areas, for which there are currently limited or no treatment options.

Ampio: Results of Injections STRUT Study

February 25, 2015 10:11 am | by Ampio Pharmaceuticals | News | Comments

Ampio Pharmaceuticals, Inc. announced results of the double-blind, multiple injection, vehicle controlled STRUT study (N=40) at 20 weeks. Read more..

Takeda Acquires Select Portfolio from Neutec to Boost Business in Turkey

February 24, 2015 3:33 pm | News | Comments

The portfolio composed of 13 products in the gastroenterology, respiratory, metabolic and musculoskeletal therapeutic areas. Read more...

FDA Approves Novartis' HDAC Inhibitor for Multiple Myeloma

February 24, 2015 3:23 pm | News | Comments

This inhibitor is the first of its kind for multiple myeloma. Read more...                               

Scientists Find Cancer Weak Spots for New Targeted Drugs

February 24, 2015 3:15 pm | by University of Sussex | News | Comments

Scientists have identified weak spots in cancer cells that could be targeted and attacked by new precision drugs. Read more...                      

Ebola Drugs Shows Some Promise in First Test in West Africa

February 24, 2015 2:57 pm | by Marilynn Marchione, AP Medical Writer | News | Comments

An experimental antiviral drug shows some early, encouraging signs of effectiveness in its first human test against Ebola in West Africa. Read more...                  

Meet Sanofi's Newest CEO

February 24, 2015 11:13 am | by Ryan Bushey, Associate Editor | Articles | Comments

It took five months to find a new chief executive. Read more...                                 

Cryoport, Sanaria Expand Logistics Partnership Supporting Malaria Vaccines

February 24, 2015 8:55 am | News | Comments

This collaboration includes continued support of Sanaria’s production of malaria vaccine as well as its research and development efforts. Read more...                 

Shire Acquires Meritage Pharma

February 24, 2015 8:48 am | News | Comments

Shire paid an upfront fee of $70 million and additional contingent payments based on the achievement of development and regulatory milestones. Read more...                 

Researchers Discover Possible Drug Target to Combat Sleeping Sickness

February 24, 2015 8:42 am | by Virginia Tech | News | Comments

Biochemists are trying to deliver a stern wake-up call to the parasite that causes sleeping sickness. Read more...                        

Merck Grants Free License for Pediatric HIV Drug

February 24, 2015 8:33 am | by Linda A. Johnson, AP Business Writer | News | Comments

The deal lets any generic or brand name drug manufacturer make low-cost pediatric versions of Merck's raltegravir for sale in 92 low- and middle-income countries. Read more...              

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading